Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VanEck Vectors Pharmaceutical ETF (PPH)

Delayed Data
As of Jul 22
 +0.17 / +0.28%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors  US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for VanEck Vectors Pharmaceutical ETF.


1 month+6.85% 3 years+11.05%
3 months+0.95% 5 years--
1 year-15.08% Since inception+14.92%
Data through 07/23/2016

Quote Details

Previous close$61.01
Open day’s range60.92 – 61.18
Net asset value (NAV)61.14 (07/22/2016)
Daily volume11,829
Average volume (3 months)66,812
Data as of 3:59pm ET, 07/22/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return--+15.32%
Expense Gross exp ratio0.41%0.47%
Risk 5 year sharpe ratio--0.99
Net assets$260.4M$1.1B
Average market cap$66.6B$35.5B
Average P/E27.320.8
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson5.32%
GSK GlaxoSmithKline5.18%
NVS Novartis5.15%
SNY Sanofi5.13%
ABBV AbbVie5.09%
BMY Bristol-Myers Squibb5.09%
MRK Merck5.08%
PFE Pfizer5.07%
LLY Eli Lilly and Co4.81%
NVO Novo Nordisk4.78%

Partner Offers

Search for Jobs